EQUITY RESEARCH MEMO

Hudson Lab Automation

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)55/100

Hudson Lab Automation, a US-based manufacturer founded in 1995, designs and produces integrated laboratory automation systems, software, and equipment. Serving drug discovery, genomics, synthetic biology, and diagnostics, the company offers custom solutions and standard products including liquid handlers, microplate handlers, workstations, and specialized tools for protein crystallography and nucleic acid extraction. By accelerating screening and enhancing precision in labor-intensive protocols, Hudson Lab Automation supports laboratories in streamlining workflows and improving throughput. Despite a lack of recent public funding or valuation data, its long-standing presence and focus on custom automation position it well in the growing lab automation market, which is driven by demand for higher efficiency in biopharma R&D and diagnostic testing.

Upcoming Catalysts (preview)

  • Q3 2026Launch of Next-Generation Liquid Handler65% success
  • TBDStrategic Partnership with a Major Pharmaceutical Company50% success
  • TBDExpansion into Genomics and Synthetic Biology Automation45% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)